BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17286158)

  • 1. Treatment of cutaneous T-cell lymphoma/mycosis fungoides.
    Parker SR; Bradley B
    Dermatol Nurs; 2006 Dec; 18(6):566-70, 573-5. PubMed ID: 17286158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.
    Duvic M
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):33-40. PubMed ID: 17474358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief primer on treatments of cutaneous T cell lymphoma, newly approved or late in development.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jul; 6(7):757-60. PubMed ID: 17763605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases.
    Buder K; Müller PA; Beckmann G; Ugurel S; Bröcker EB; Becker JC
    Acta Derm Venereol; 2014 Jan; 94(1):94-6. PubMed ID: 23756575
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycosis fungoides.
    Pitman J; Muekusch G
    Dermatol Nurs; 2007 Aug; 19(4):377. PubMed ID: 17874608
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of mycosis fungoides.
    Galper SL; Smith BD; Wilson LD
    Oncology (Williston Park); 2010 May; 24(6):491-501. PubMed ID: 20568590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
    Saleh MN; LeMaistre CF; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Sams MW; Nichols JC
    J Am Acad Dermatol; 1998 Jul; 39(1):63-73. PubMed ID: 9674399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
    Bunn PA
    Arch Dermatol; 1995 May; 131(5):603-5. PubMed ID: 7537952
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
    Talpur R; Duvic M
    Clin Lymphoma Myeloma; 2006 May; 6(6):488-92. PubMed ID: 16796781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis, staging, and treatment options for mycosis fungoides.
    Keehn CA; Belongie IP; Shistik G; Fenske NA; Glass LF
    Cancer Control; 2007 Apr; 14(2):102-11. PubMed ID: 17387295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycosis fungoides].
    Richard-Lallemand MA; Carsuzaa F
    Ann Dermatol Venereol; 1997; 124(1):69-90. PubMed ID: 9686047
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cutaneous T cell lymphoma: current status and future directions.
    Apisarnthanarax N; Talpur R; Duvic M
    Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denileukin diftitox therapy for patients with tumour-stage mycosis fungoides.
    Assaf C
    Dermatol Clin; 2008 Jan; 26 Suppl 1():21-2. PubMed ID: 18405182
    [No Abstract]   [Full Text] [Related]  

  • 17. Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.
    Duvic M
    Hematology Am Soc Hematol Educ Program; 2015; 2015():529-44. PubMed ID: 26637769
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma.
    Rook AH; Junkins-Hopkins JM; McGinnis KS; Wysocka M; Richardson SK; Budgin JB; Everitts S; Vittorio CC
    Adv Dermatol; 2002; 18():29-43. PubMed ID: 12528401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choices in the treatment of cutaneous T-cell lymphoma.
    Hymes KB
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):18-23. PubMed ID: 17474355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema gyratum repens-like eruptions with large cell transformation in a patient with mycosis fungoides.
    Holcomb M; Duvic M; Cutlan J
    Int J Dermatol; 2012 Oct; 51(10):1231-3. PubMed ID: 21726213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.